-
hematopoietic cell development and hematologic cancers. Based on these basic mechanistic insights, the Laboratory is building innovative therapeutics to treat hematopoietic cancers that are currently without
-
performed an RNA-seq screen in mouse embryonic stem cells and neural progenitor cells and identified differentially expressed lncRNAs. The proposed studies will build upon these findings and use innovative
-
scientific discoveries. PhD candidates expecting to complete by 2024 are encouraged to apply. Candidates with expertise in organic synthesis, peptide/ natural product/macrocycle chemistry, or chemical biology
-
of neural circuitry across rodent species to bridge this knowledge-gap. Position Requirements Candidates must hold a PhD degree (or equivalent) in neuroscience, biomedical engineering or a related field. The